Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Por um escritor misterioso
Descrição
Frontiers COVID-19 vaccination in patients with cancer: Opportunities and challenges
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Frontiers Adaptive Immune Responses and Immunity to SARS-CoV-2
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines - Sette - 2022 - Immunological Reviews - Wiley Online Library
Frontiers Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era - ScienceDirect
State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study - eClinicalMedicine
Cancers, Free Full-Text
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Vaccines, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
